PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New study suggests that SARS-CoV-2 might induce lasting pain in unique way

Findings may contribute to the understanding of pathophysiology and help validate novel therapies for the prevention and treatment of COVID-19

2023-05-09
(Press-News.org) (Boston)—COVID-19, the disease resulting from SARS-CoV-2 infection, is associated with highly variable clinical outcomes that range from asymptomatic disease to death. For those with milder infections, COVID-19 can produce respiratory infection symptoms (cough, congestion, fever) and sensory phenotypes such as headache and loss of sense of smell. In more severe cases, SARS-CoV-2 infection can affect nearly every organ and result in strokes from vascular occlusion, cardiovascular damage and acute renal failure. A substantial number of actively infected patients suffering from both mild and severe infections experience sensory-related symptoms, such as headache, visceral pain, Guillain-Barre syndrome, nerve pain and inflammation. In most patients these symptoms subside after the infection ends, but, for other patients, they can persist.

 

In a new study, researchers from Boston University Chobanian & Avedisian School of Medicine, Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) and New York University (NYU), have found that thousands of genes were affected by SARS-CoV-2-mediated disease even after the viral infection had been cleared. These genes were associated with neurodegeneration and pain-related pathways, suggesting lasting damage to dorsal root ganglia (spinal nerves that carry sensory messages from various receptors) that may underlie symptoms of Post-Covid Conditions also known as Long Covid.

  “Several studies have found that a high proportion of Long Covid patients suffer from abnormal perception of touch, pressure, temperature, pain or tingling throughout the body. Our work suggests that SARS-CoV-2 might induce lasting pain in a rather unique way, emphasizing the need for therapeutics that target molecular pathways specific to this virus,” explains corresponding author Venetia Zachariou, PhD, chair of pharmacology, physiology & biophysics at BU Chobanian & Avedisian School of Medicine. This work was performed in collaboration with Benjamin tenOever, PhD, professor of microbiology and medicine at NYU, formerly at Icahn Mount Sinai.  

Using an experimental model infected with SARS-CoV-2, the researchers studied the effects of infection on sensitivity to touch, both during active infection and well after the infection had cleared. They then compared the effects of SARS-CoV-2 to those triggered by influenza A virus infection. In the experimental model, they observed a slow but progressive increase in sensory sensitivity over time – one that differed substantially from viral control, influenza A virus, which caused quick hypersensitivity during active infection but returned to normal by the time infection was over.

 

According to the researchers, this model can be used to gain information on genes and pathways affected by SARS-CoV-2, providing novel information to the scientific community on gene expression changes in sensory ganglia several weeks after infection.

 

“We hope this study will provide new avenues for addressing somatosensory symptoms of long COVID and ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome), which are only just now beginning to be addressed by mainstream medicine. While we have begun using this information by validating one promising target in this study, we believe our now publicly available data can yield insights into many new therapeutic strategies,” adds Zachariou. 

 

These findings appear online in the journal Science Signaling.

 

This study was supported by National Institute of Neurological Disorders and Stroke NS086444S1 (R.A.S), the Zegar Family Foundation (B.T.) and the Friedman Brain Institute Research Scholars Program (V.Z., B.T., R.A.S., J.J.F.).

 

Note to Editors:

 

RAS, JJF, BT, and VZ are inventors on a patent covering the utility of ILF3 inhibition for the treatment of various forms of pain filed through Mount Sinai Innovation Partners.

 

Mount Sinai Innovation Partners filed a patent application on compositions and methods of ILF3 inhibition for the treatment of various forms of pain.

 

END



ELSE PRESS RELEASES FROM THIS DATE:

New method uses engineered bacteria and AI to sense and record environmental signals

New method uses engineered bacteria and AI to sense and record environmental signals
2023-05-09
New Method Uses Engineered Bacteria and AI to Sense and Record Environmental Signals Columbia synthetic biologists first to engineer bacterial swarm patterns to visibly record environment, use deep learning to decode patterns; applications could range from monitoring environmental pollution to building living materials  New York, NY—May 9, 2023—Researchers in Biomedical Engineering Professor Tal Danino’s lab were brainstorming several years ago about how they could engineer and apply naturally-pattern-forming bacteria. There are many bacteria species, such as Proteus mirabilis (P. mirabilis), that self-organize into defined patterns on solid surfaces that are visible ...

Increasing prosperity linked to unhealthy eating patterns in Kenyan youth

2023-05-09
Philadelphia, May 9, 2023 – The increase in obesity in lower-middle-income countries (LMIC) is largely thought to be affected by lifestyle transition away from traditional diets toward unhealthy Western dietary patterns that follow economic development. This study in the Journal of Nutrition Education and Behavior, published by Elsevier, collected data on eating and physical activity behaviors from families in two socioeconomically-different communities in Nairobi, Kenya. Researchers found that increasing prosperity is linked to unhealthy eating patterns in Kenyan preadolescents. "Dietary ...

Systematic racism in healthcare boosted COVID-19 vaccine mistrust in Black communities: Study

Systematic racism in healthcare boosted COVID-19 vaccine mistrust in Black communities: Study
2023-05-09
The University of Ottawa’s Interdisciplinary Centre for Black Health survey reveals scope of coronavirus vaccine hesitancy in Black communities in relation to healthcare. The health care system must play a significant role in combatting COVID-19 mistrust among Black individuals in Canada according to a new University of Ottawa study that found distrust in the healthcare network was so profound that educated individuals were hesitant to receive the vaccine. Professor Jude Mary Cénat, Associate Professor in the School of Psychology at the Faculty of Social Sciences, is the Chair of the Interdisciplinary Centre ...

Hey Siri, can you hear me? #ASA184

Hey Siri, can you hear me? #ASA184
2023-05-09
CHICAGO, May 9, 2023 – Millions of people now regularly communicate with AI-based devices, such as smartphones, speakers, and cars. Studying these interactions can improve AI’s ability to understand human speech and determine how talking with technology impacts language. In their talk, “Clear speech in the new digital era: Speaking and listening clearly to voice-AI systems,” Georgia Zellou and Michelle Cohn of the University of California, Davis will describe experiments to investigate how speech and comprehension change when humans communicate ...

Lack of belief in body’s ability to function through pain linked to daily pre-surgery prescribed opioid use among candidates for elective spine surgery

2023-05-09
According to a new Johns Hopkins Medicine study, low pain self-efficacy can predict daily pre-surgery prescribed opioid use among patients seeking elective spine surgery. The study defined pain self-efficacy as the “beliefs held by people with chronic pain that they can carry out certain activities, even when experiencing pain.” Previous studies showed that lower pain self-efficacy is associated with higher pain intensity and greater pain interference in day-to-day life. However, the Johns Hopkins research team believes its study is among the first to investigate ...

Reduced cancer mortality with daily vitamin D intake

2023-05-09
Vitamin D intake could reduce cancer mortality in the population by twelve percent - provided the vitamin is taken daily. This was the result of an evaluation of 14 studies of the highest quality conducted at the German Cancer Research Center with a total of almost 105,000 participants. Vitamin D deficiency is widespread worldwide and is particularly common among cancer patients. Averaged over the year, the vitamin D blood levels of about 15 percent of German adults are below the threshold for a pronounced vitamin D deficiency*. In contrast, in a study of colorectal ...

Scientists develop AI tool to predict Parkinson’s disease onset

2023-05-09
Scientists from UNSW Sydney with collaborators at Boston University have developed a tool that shows early promise in detecting Parkinson’s disease years before the first symptoms start appearing. In research published today in the journal ACS Central Science, the researchers described how they used neural networks to analyse biomarkers in patients’ bodily fluids. The researchers from UNSW School of Chemistry examined blood samples taken from healthy individuals gathered by the Spanish European ...

SwRI selected for Phase A study to develop next-generation NOAA coronagraph

SwRI selected for Phase A study to develop next-generation NOAA coronagraph
2023-05-09
SAN ANTONIO — May 9, 2023 —NASA has selected Southwest Research Institute for a Phase A study to develop SwRI’s Space Weather Solar Coronagraph (SwSCOR) on behalf of the National Oceanic and Atmospheric Administration (NOAA). NOAA’s Space Weather Next Program is charged with providing critical data for its space weather prediction center. SwRI is one of five organizations developing a definition-phase study to produce the next-generation NOAA L1 Series COR instrument to detect and characterize Earth-directed coronal mass ejections (CMEs). CMEs are huge bursts of coronal plasma threaded with intense magnetic fields ...

Long molecule of RNA essential to our GI tract’s ability to contract and move food along

Long molecule of RNA essential to our GI tract’s ability to contract and move food along
2023-05-09
AUGUSTA, Ga. (May 9, 2023) –  A long molecule of RNA found in abundance in the healthy smooth muscle cells that give our blood vessels strength and flexibility is also essential to the continuous contraction that moves food through our gastrointestinal tract. Without CARMN, a long, noncoding RNA, which means it doesn’t produce proteins but does help regulate cell activity, the 30-foot-long GI tract doesn’t contract as it should. That can result in a painful even lethal situation where partially undigested food gets ...

A CRISPR-edited calf shows virus resistance 

A CRISPR-edited calf shows virus resistance 
2023-05-09
A gene-edited calf shows resistance to a common bovine virus. Bovine viral diarrhea virus (BVDV) causes gastrointestinal and respiratory symptoms as well as reproductive failure in cattle around the world. Vaccines against the virus exist but the virus evolves quickly and vaccines are not always fully protective. Aspen Workman and colleagues used the CRISPR/Cas9 system to swap out just six amino acids in the bovine CD46 receptor in one calf. The calf showed a dramatic reduction in susceptibility to the virus and ...

LAST 30 PRESS RELEASES:

NASA scientists find new human-caused shifts in global water cycle

This tiny galaxy is answering some big questions

Large and small galaxies may grow in ways more similar than expected

The ins and outs of quinone carbon capture

Laboratory for Laser Energetics at the University of Rochester launches IFE-STAR ecosystem and workforce development initiatives

Most advanced artificial touch for brain-controlled bionic hand

Compounding drought and climate effects disrupt soil water dynamics in grasslands

Multiyear “megadroughts” becoming longer and more severe under climate change

Australopithecines at South African cave site were not eating substantial amounts of meat

An AI model developed to design proteins simulates 500 million years of protein evolution in developing new fluorescent protein

Fine-tuned brain-computer interface makes prosthetic limbs feel more real

New chainmail-like material could be the future of armor

The megadroughts are upon us

Eavesdropping on organs: Immune system controls blood sugar levels

Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors

New study reveals how climate change may alter hydrology of grassland ecosystems

Polymer research shows potential replacement for common superglues with a reusable and biodegradable alternative 

Research team receives $1.5 million to study neurological disorders linked to long COVID

Research using non-toxic bacteria to fight high-mortality cancers prepares for clinical trials

Do parents really have a favorite child? Here’s what new research says

Mussel bed surveyed before World War II still thriving

ACS Annual Report: Cancer mortality continues to drop despite rising incidence in women; rates of new diagnoses under 65 higher in women than men

Fewer skin ulcers in Werner syndrome patients treated with pioglitazone

Study finds surprising way that genetic mutation causes Huntington’s disease, transforming understanding of the disorder

DNA motors found to switch gears

Human ancestor thrived longer in harsher conditions than previous estimates

Evolution: Early humans adapted to extreme desert conditions over one million years ago

Race and ethnicity and diffusion of telemedicine in Medicaid for schizophrenia care after onset of the COVID-19 pandemic

Changes in support for advance provision and over-the-counter access to medication abortion

Protein level predicts immunotherapy response in bowel cancer

[Press-News.org] New study suggests that SARS-CoV-2 might induce lasting pain in unique way
Findings may contribute to the understanding of pathophysiology and help validate novel therapies for the prevention and treatment of COVID-19